Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The new visual scale is a quick and effective way to measure hair loss in women.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.

The vellus index is a simple, quick, and reliable method to assess and monitor hair growth, especially in hirsutism.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Videodermoscopy can help diagnose and monitor nail bed psoriasis.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Phototherapy is effective and well-tolerated for treating childhood psoriasis and pityriasis lichenoides chronica.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.